Purchase Order 75N95D25P00092

Award Date 9/15/25
Potential Completion Date 9/14/26
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,600 firm fixed price purchase order awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract was awarded to C M Cherry Consulting LLC, a self-certified small disadvantaged business, for laboratory services related to the computational analysis of single-cell RNA-sequencing data. The work is to be performed in the Baltimore, MD area, with a period of performance...
<p>This is a $23,760.00 firm fixed price purchase order awarded by the National Institutes of Health (NIH), which is part of the Department of Health and Human Services, to C M Cherry Consulting LLC, a self-certified small disadvantaged business. The contract is for services to be performed in Potomac, Maryland and has a completion date of July 22, 2024. There is no set-aside designation mentioned for this award.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,750 firm fixed price purchase order to C M Cherry Consulting LLC of Rockville, Maryland for lab testing services. The contract has a period of performance through November 15, 2023 and was awarded on May 15 without a set-aside designation. C M Cherry Consulting LLC represented itself as a self-certified small disadvantaged business operating as a for-profit limited liability company....
<p>This is a firm fixed-price purchase order awarded by the National Institute on Aging, a civilian federal agency, to Quick Biology Inc., a small disadvantaged business located in Monrovia, California. The contract is for $20,364.16 and provides laboratory and testing services, specifically RNA sequencing, with a performance period ending on April 17, 2025. The contract does not have a set-aside designation.</p>
C M Cherry Consulting LLC has been awarded a $23,760 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for C M Cherry Consulting LLC to provide unspecified services to NIDA from its place of performance in Potomac, Maryland, over a six-month period concluding in January 2024. No major subcontractors or set-aside designations were...
This is a $720,000 labor hours purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, to Ml_Consult LLC, a for-profit limited liability company, to provide therapeutic oligonucleotide platform biologics chemistry, manufacturing and controls (CMC) subject matter expert consulting services. The services are in support of NINDS's Ultra-Rare Gene Therapy program, the NIH Blueprint Neurotherapeutics Biologics program, and...
This is a purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency under the Department of Health and Human Services, to Quick Biology Inc. for RNA sequencing services. The $13,260.00 firm fixed-price contract is to support research related to aging and senescence. Quick Biology Inc. is a small disadvantaged business that has previously provided genomics services to other federal agencies such as the Agricultural Research Service and National Institute on...
This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a part of the National Institutes of Health (NIH), to Singulomics Corp, a biotechnology company specializing in single cell omics research and services. The $27,893 contract is for DNA single cell sequencing of mouse tissue specimens to support NIA's research on Alzheimer's disease and related dementias. The period of performance is from July 19, 2021 to December 1, 2021. This contract was not set aside...
<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian agency, to Quick Biology Inc., a self-certified small disadvantaged business. The contract, valued at $102,060.00, is for SNRNASEQ analysis of senolytics in the aging kidney and lung. The contract has a total small business set-aside designation and a performance period ending on May 8, 2025. No additional subcontractors were indicated in the provided information.</p>
This firm fixed-price purchase order awards Psomagen Inc. $422,000 to provide RNA sequencing services to the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), from June 2021 through June 2023. The contract supports NIA research on Alzheimer's disease and related dementias by requiring the contractor to construct sequencing libraries from 20 human samples, perform sequencing on an Illumina NovaSeq 6000 platform, and deliver various data files. No set-aside...

This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to C M Cherry Consulting LLC, a self-certified small disadvantaged business located in Baltimore, Maryland. The contract, valued at $24,900.00, is for analytical testing services, specifically single-cell ribonucleic acid (RNA) and multiome analysis. The contract has an ultimate completion date of September 14, 2026. C M Cherry Consulting LLC has demonstrated expertise in computational analysis of single-cell RNA-sequencing data, transcriptional profiling of immune cells, and specialized laboratory testing services, having successfully secured multiple federal contract awards from various NIH components. This contract does not have a set-aside designation, indicating it was competed in the open market.

Generated 9/16/25, 10:05 AM